Assisted Reproductive Technology: Clinical Advances and Challenges
Deadline for manuscript submissions: 25 August 2024 | Viewed by 191
Interests: ovarian reserve; antral follicle count; 3D-AFC; anti-Mullerian hormone; fertility preservation; fertility in multiple sclerosis; assisted reproductive technology; IVF pregnancy
Interests: antral follicle count; 3D-AFC; anti-Mullerian hormone; fertility preservation; endometriosis; assisted reproductive technology; reproductive endocrinology; IVF pregnancy; recurrent implantation failure; reproductive immunology
Nowadays, assisted reproductive technology (ART) treatments are becoming increasingly in demand, due to social reasons such as late motherhood and the improvements in the management of chronic degenerative and neoplastic disease allowing fertility preservation and family planning, among others. Therefore, many aspects of the process are continuously studied, refined and renewed to increase the chance of live birth. The aim of this Special Issue is to provide a wide overview of the recent advances in assisted reproduction, and to eventually explore the challenges of any step of the treatment, from the inclusion criteria (or diseases to consider) to allowing a couple to perform ART treatments or fertility preservation, the evaluation of the ovarian reserve (new methods such as 3D.antral follicle count), ovarian stimulation protocols (dual trigger, dual stimulation, gonadotrophin dose and type, pharmacogenomics), embryo transfer and endometrial preparation with the window of implantation and endometrial receptivity (endometrial metabolism, immunology and microbiome) and pregnancy outcomes after IVF. Hence, researchers in the field of reproductive medicine are encouraged to submit their findings as original articles or reviews to this Special Issue.
Dr. Luigi Carbone
Dr. Raffaella Di Girolamo
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- endometrial microbiome
- endometrial receptivity
- recurrent implantation failure
- preimplantation genetic testing
- artificial intelligence in ART
- Poseidon classification
- fertility preservation
- immunology of reproduction
- assisted reproductive technology
- ovarian stimulation